XML 44 R27.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Organization and Business (Details Narrative)
1 Months Ended 3 Months Ended 12 Months Ended
May 30, 2023
USD ($)
shares
Mar. 31, 2024
USD ($)
integer
Mar. 31, 2023
Dec. 31, 2023
USD ($)
shares
May 28, 2021
USD ($)
Number of patents issued | integer   19      
Number of pending patents | integer   8      
Cash and cash equivalents   $ 2,000,000      
Net working capital   1,500,000      
Accumulated deficit   $ (169,558,869)   $ (167,447,211)  
Customer One, Two, and Three | Net Revenue | Customer Concentration Risk          
Percentage of concentration risk     66.30%    
Customer One | Net Revenue | Customer Concentration Risk          
Percentage of concentration risk   75.90% 26.40%    
Customer One | Accounts Receivable | Customer Concentration Risk          
Percentage of concentration risk   53.80%      
Customer Two | Net Revenue | Customer Concentration Risk          
Percentage of concentration risk     25.30%    
Customer Three | Net Revenue | Customer Concentration Risk          
Percentage of concentration risk     14.60%    
Two Largest Customers | Accounts Receivable | Customer Concentration Risk          
Percentage of concentration risk     24.00%    
Common Share Or Stock Member          
Shares issued in registered direct offering (in shares) | shares       173,558  
Capital raise, net of issuance costs       $ 63,136  
Commissions       $ 1,902  
Registered Direct Offering          
Sale of stock, consideration received on transaction $ 4,000,000.0        
Shares issued in registered direct offering (in shares) | shares 16,000,000        
Sales Agreement          
Sale of stock, consideration received on transaction, authorized amount         $ 35,000,000
Commission fee, percent         3.00%